Pulmonary hypertension primary and Complications of maternal exposure to therapeutic drugs

Summary:

Complications of maternal exposure to therapeutic drugs is reported only by a few people with Pulmonary hypertension primary.

The study analyzes which people have Complications of maternal exposure to therapeutic drugs with Pulmonary hypertension primary. It is created by eHealthMe based on 5 people who have Complications of maternal exposure to therapeutic drugs and Pulmonary hypertension primary from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 26, 2023

5 people who have Pulmonary Hypertension Primary and Complications Of Maternal Exposure To Therapeutic Drugs are studied.

What is Pulmonary hypertension primary?

Pulmonary hypertension primary (increase in blood pressure in the lung artery with no cause) is found to be associated with 233 drugs and 13 conditions by eHealthMe.

What is Complications of maternal exposure to therapeutic drugs?

Complications of maternal exposure to therapeutic drugs is found to be associated with 861 drugs and 546 conditions by eHealthMe.

Number of Complications of maternal exposure to therapeutic drugs in Pulmonary hypertension primary reports submitted per year:

Would you have Complications of maternal exposure to therapeutic drugs when you have Pulmonary hypertension primary?

Gender of people who have Pulmonary Hypertension Primary and experienced Complications Of Maternal Exposure To Therapeutic Drugs *:

female: 100 %
male: 0.0 %

Age of people who have Pulmonary Hypertension Primary and experienced Complications Of Maternal Exposure To Therapeutic Drugs *:

Common drugs taken by these people *:

Tracleer: 5 people, 100.00%
Progesterone: 2 people, 40.00%
Heparin: 2 people, 40.00%
Coumadin: 2 people, 40.00%
Warfarin Sodium: 1 person, 20.00%

Common symptoms for these people *:

Birth Control: 2 people, 40.00%
Premature Baby: 1 person, 20.00%
High Blood Pressure: 1 person, 20.00%
Dyspnea Exacerbated: 1 person, 20.00%
Drug Exposure During Pregnancy: 1 person, 20.00%
Cardiac Arrest: 1 person, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Complications of maternal exposure to therapeutic drugs?

Check whether Complications of maternal exposure to therapeutic drugs is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Treatments, associated drugs and conditions:

Pulmonary hypertension primary (2,539 reports)
Complications of maternal exposure to therapeutic drugs (5,945 reports)

COVID vaccines that are related to Complications of maternal exposure to therapeutic drugs:

Common drugs associated with Complications of maternal exposure to therapeutic drugs:

All the drugs that are associated with Complications of maternal exposure to therapeutic drugs:

Complications of maternal exposure to therapeutic drugs (861 drugs)

Common conditions associated with Complications of maternal exposure to therapeutic drugs:

Hiv infection: 406 reports
Birth control: 199 reports
Depression: 167 reports

All the conditions that are associated with Complications of maternal exposure to therapeutic drugs:

Complications of maternal exposure to therapeutic drugs (546 conditions)

How the study uses the data?

The study is based on Complications of maternal exposure to therapeutic drugs and Pulmonary hypertension primary, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.